We are live on ! Find out more
CTXRW

Citius Pharmaceuticals, Inc. Warrant
CTXRW

Delisted

CTXRW was delisted on the 8th of August, 2022.

Back to rankings

2 hedge funds and large institutions have $3K invested in Citius Pharmaceuticals, Inc. Warrant in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 1 → 2 (+1)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$3.06K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$90
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$3K +$3.06K +11,049 New
UBS Group
2
UBS Group
Switzerland
– -$90 -325 -30%

CTXRW Hedge Fund Activity: Q1 2019 in Review

2 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Citius Pharmaceuticals, Inc. Warrant (CTXRW) for Q1 2019, worth a combined $3K.

Buyers outnumbered sellers: 1 fund opened new CTXRW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $3.06K. The largest seller was UBS Group, cutting an estimated $90.

  • 2 institutional investors held Citius Pharmaceuticals, Inc. Warrant (CTXRW) as of Q1 2019, up from 1 in Q4 2018.
  • Funds reported $3K of Citius Pharmaceuticals, Inc. Warrant stock for Q1 2019.
  • 1 fund opened new Citius Pharmaceuticals, Inc. Warrant positions in Q1 2019 and 0 closed out, a net change of +1 holder.
  • The largest Citius Pharmaceuticals, Inc. Warrant buyer in Q1 2019 was Susquehanna International Group, an estimated $3.06K added.
  • The largest Citius Pharmaceuticals, Inc. Warrant seller in Q1 2019 was UBS Group, an estimated $90 sold.

Based on aggregated 13F filings for Q1 2019.